Glyco-Engineering of Plant-Based Expression Systems
- 2 August 2018
- book chapter
- Published by Springer Nature
- Vol. 175, 137-166
Abstract
Most secreted proteins in eukaryotes are glycosylated, and after a number of common biosynthesis steps the glycan structures mature in a species-dependent manner. Therefore, human therapeutic proteins produced in plants often carry plant-like rather than human-like glycans, which can affect protein stability, biological function, and immunogenicity. The glyco-engineering of plant-based expression systems began as a strategy to eliminate plant-like glycans and produce human proteins with authentic or at least compatible glycan structures. The precise replication of human glycans is challenging, owing to the absence of a pathway in plants for the synthesis of sialylated proteins and the necessary precursors, but this can now be achieved by the coordinated expression of multiple human enzymes. Although the research community has focused on the removal of plant glycans and their replacement with human counterparts, the presence of plant glycans on proteins can also provide benefits, such as boosting the immunogenicity of some vaccines, facilitating the interaction between therapeutic proteins and their receptors, and increasing the efficacy of antibody effector functions.Keywords
This publication has 166 references indexed in Scilit:
- The immunomodulatory effect of plant lectins: a review with emphasis on ArtinM propertiesGlycoconjugate Journal, 2013
- GMP issues for recombinant plant-derived pharmaceutical proteinsBiotechnology Advances, 2012
- Towards high-yield production of pharmaceutical proteins with plant cell suspension culturesBiotechnology Advances, 2011
- Relevant Elements of a Maize γ-Zein Domain Involved in Protein Body BiogenesisJournal of Biological Chemistry, 2010
- In Planta Protein Sialylation through Overexpression of the Respective Mammalian PathwayJournal of Biological Chemistry, 2010
- Improved Virus Neutralization by Plant-produced Anti-HIV Antibodies with a Homogeneous β1,4-Galactosylated N-Glycan ProfileJournal of Biological Chemistry, 2009
- Recent insights into the biological roles of mucin-type O-glycosylationGlycoconjugate Journal, 2008
- Cetuximab-Induced Anaphylaxis and IgE Specific for Galactose-α-1,3-GalactoseNew England Journal of Medicine, 2008
- Cost-effective production of a vaginal protein microbicide to prevent HIV transmissionProceedings of the National Academy of Sciences, 2008
- An antibody produced in tobacco expressing a hybrid β-1,4-galactosyltransferase is essentially devoid of plant carbohydrate epitopesProceedings of the National Academy of Sciences, 2006